| Drug Name |
Fludeoxyglucose f-18 |
| Drug ID |
BADD_D00916 |
| Description |
Fludeoxyglucose F 18 Injection is a positron emitting radiopharmaceutical containing no-carrier added radioactive 2-deoxy-2-[18F]fluoro-D-g1ucose, which is used for diagnostic purposes in conjunction with Positron Emission Tomography (PET). It is administered by intravenous injection. |
| Indications and Usage |
The uptake of 18F-FDG by tissues is a marker for the tissue uptake of glucose, which in turn is closely correlated with certain types of tissue metabolism.
Fludeoxyglucose F 18 Injection is indicated in positron emission tomography (PET) imaging for assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnoses of cancer. |
| Marketing Status |
approved; investigational |
| ATC Code |
Not Available |
| DrugBank ID |
DB09502
|
| KEGG ID |
Not Available
|
| MeSH ID |
D019788
|
| PubChem ID |
450503
|
| TTD Drug ID |
D0H2RI
|
| NDC Product Code |
16129-001; 52768-001; 78714-001; 24450-647; 29998-001; 24562-001; 24562-003; 40098-101; 60055-334; 65857-150; 76318-334; 49609-101; 24417-001; 76376-618; 52670-551 |
| UNII |
0Z5B2CJX4D
|
| Synonyms |
Fluorodeoxyglucose F18 | F18, Fluorodeoxyglucose | 18F-FDG | Fluorodeoxyglucose F 18 | F 18, Fluorodeoxyglucose | Fludeoxyglucose F 18 | F 18, Fludeoxyglucose | Fluorine-18-fluorodeoxyglucose | Fluorine 18 fluorodeoxyglucose | 18F Fluorodeoxyglucose | Fluorodeoxyglucose, 18F | 18FDG | 2-Fluoro-2-deoxy-D-glucose | 2 Fluoro 2 deoxy D glucose | 2-Fluoro-2-deoxyglucose | 2 Fluoro 2 deoxyglucose |
